Background illustration for clinical trials search

Paid Clinical Trials Victorville

Discover 1,139 paid clinical trials in Victorville, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2
Featured

A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab

for
Atopic Dermatitis
Location: Pasadena CA, Fountain Valley CA, Mission Viejo CA,
Sponsor: AbbVie

Sex: All

Age: 18 - 63

Code: NCT06389136

Phase3, Recruiting

A Single Dose, Phase 1 Study of JADE101 in Healthy Japanese and Chinese Participants

for
Healthy Volunteers (HV)
Location: Glendale CA
Sponsor: Jade Biosciences, Inc.

Sex: All

Age: 18 - 55

Code: NCT07525947

Phase1, Recruiting

AV-101 Alone and in Combination With Probenecid in Healthy Subjects

for
Drug Drug Interaction
Location: Glendale CA
Sponsor: VistaGen Therapeutics, Inc.

Sex: All

Age: 18 - 55

Code: NCT05280054

Phase1, Recruiting

PODOMOUNT-Basket, a Study to Test Whether BI 764198 Helps Adults and Adolescents With Different Types of Kidney Disease

for
Proteinuric Kidney Diseases
Location: Glendale CA, Los Angeles CA, Granada Hills CA,
Sponsor: Boehringer Ingelheim

Sex: All

Age: 12+

Code: NCT07355296

Phase2, Recruiting

A Safety and Efficacy Study of EIK1001 in Combination With Pembrolizumab and Chemotherapy in Participants With Stage 4 Non-Small Cell Lung Cancer.

for
Non Small Cell Lung Cancer (Squamous or Non Squamous),
Location: Glendale CA, Orange CA, Albuquerque NM, Pueblo CO,
Sponsor: Eikon Therapeutics

Sex: All

Age: 18+

Code: NCT07365319

Phase2, Phase3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study to Compare Setidegrasib (ASP3082) With Docetaxel, in People With Non-small Cell Lung Cancer With a KRAS G12D Mutation

for
Non-small Cell Lung Cancer (NSCLC)
Location: Glendale CA, San Francisco CA, Arlington VA, Edison NJ
Sponsor: Astellas Pharma Global Development, Inc.

Sex: All

Age: 18+

Code: NCT07566052

Phase3, Recruiting

A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy

for
Colorectal Neoplasms
Location: Glendale CA, Los Angeles CA, Los Alamitos CA,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT06750094

Phase3, Recruiting

A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer

for
Colorectal Neoplasms
Location: Glendale CA, Los Angeles CA, Los Alamitos CA,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT06662786

Phase3, Recruiting

A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.

for
Metastatic Castration-Resistant Prostate Cancer
Location: Glendale CA, Anaheim CA, Los Angeles CA,
Sponsor: Pfizer

Sex: Male

Age: 18+

Code: NCT06629779

Phase3, Recruiting

Cryoablation as a Minimally Invasive Alternative to Surgery for Managing Ductal Carcinoma In Situ

for
Ductal Carcinoma in Situ
Location: Glendale CA
Sponsor: Glendale Adventist Medical Center d/b/a Adventist Health Glendale

Sex: Female

Age: 18+

Code: NCT05218044

Recruiting

A Study to Assess the Safety, Tolerability, and Pharmacokinetics of GIGA-2339 in Participants With Chronic Hepatitis B Virus Infection

for
Hepatitis B Virus Infection
Location: Huntington Beach CA, Lake Forest CA, Long Beach CA,
Sponsor: GigaGen, Inc.

Sex: All

Age: 18+

Code: NCT07024641

Phase1, Recruiting

REvascularization CHoices Among Under-Represented Groups Evaluation: The RECHARGE Trial - Minorities

for
Coronary Artery Disease
Location: Glendale CA, Dallas TX, Memphis TN, Nashville TN,
Sponsor: Weill Medical College of Cornell University

Sex: All

Age: 18+

Code: NCT06399705

Phase3, Recruiting

REvascularization CHoices Among Under-Represented Groups Evaluation: The RECHARGE Trial - Women

for
Coronary Artery Disease
Location: Glendale CA, Dallas TX, Memphis TN, Nashville TN,
Sponsor: Weill Medical College of Cornell University

Sex: All

Age: 18+

Code: NCT06399692

Phase3, Recruiting

Discovering Novel Cancer Treatment Options Using a Comprehensive NGS-based Molecular Testing Panel in the Community Setting ("DINOSAur")

for
Stage III Solid Tumors, Stage IV Solid Tumors
Location: Glendale CA
Sponsor: Glendale Adventist Medical Center d/b/a Adventist Health Glendale

Sex: All

Age: 18+

Code: NCT05692466

Recruiting

A Study to Evaluate the Efficacy and Safety of TL118 in Solid Tumors Patients

for
Solid Tumor
Location: Glendale CA, Dallas TX, Houston TX
Sponsor: Teligene US

Sex: All

Age: 18+

Code: NCT06010342

Phase2, Recruiting
New

Post-Marketing Study for Early-Stage Low-Risk Breast Cancer Treatment Using ProSense® Cryoablation (ChoICE Trial)

for
Low-Risk, Early Stage Breast Cancer
Location: Glendale CA, Germantown TN
Sponsor: IceCure Medical Ltd.

Sex: All

Age: 70+

Code: NCT07629206

Recruiting

Project 2: Optimizing Engagement and Outcomes in STAND Digital Therapy

for
Depression, Anxiety
Location: Los Angeles CA
Sponsor: University of California, Los Angeles

Sex: All

Age: 18 - 40

Code: NCT05908565

Recruiting

S.T.A.N.D. Alacrity Center Signature Project

for
Depression, Anxiety
Location: Los Angeles CA
Sponsor: University of California, Los Angeles

Sex: All

Age: 18 - 40

Code: NCT05591937

Recruiting

Safety and Drug Concentrations of REGN20934 in Adults With Overweight or Obesity

for
Overweight or Obesity
Location: Glendale CA
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18 - 65

Code: NCT07594093

Phase1, Recruiting

A Trial to Evaluate the Safety Tolerability and Pharmacokinetics of B1344 by Subcutaneous Injection in Healthy Subjects

for
Nonalcoholic Steatohepatitis
Location: Glendale CA
Sponsor: Tasly Biopharmaceuticals Co., Ltd.

Sex: All

Age: 18 - 55

Code: NCT05655221

Phase1, Recruiting